Yoon H L, Singh K P, Ratner S, Reiners J J
Institute of Chemical Toxicology, Wayne State University, Detroit, MI 48201, USA.
Carcinogenesis. 1996 Dec;17(12):2617-24. doi: 10.1093/carcin/17.12.2617.
SSIN mice are considerably more sensitive to the effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in two-stage skin carcinogenesis protocols than are most other strains and stocks of mice. Experiments were performed to determine whether there was an immunological basis for this sensitivity. SSIN mice were haplotyped and found to be H-2q. T cells represented approximately 31% of the splenic cellularity of non-treated SSIN mice, but approximately 44% in BALB/c, C57BL/6, B6C3F1 and SENCAR mice. Splenic CD4+/CD8+ T cell ratios were approximately 4.2, 2.9, 2.4, 1.8 and 1.7 in SSIN, SENCAR, BALB/c, B6C3F1 and C57BL/6 mice, respectively. The unusually high ratio in SSIN spleens was the consequence of reductions in CD8+ T cells. The ratio of CD4+/CD8+ T cells in SSIN thymocytes was similiar to that measured in the spleen. The splenic cytotoxic T lymphocyte (CTL) activities of the various murine strains inversely correlated with their splenic CD4+/CD8+ ratios and their sensitivities in two-stage skin carcinogenesis protocols. Repeated in vivo topical treatment of SSIN mice with TPA caused significant decreases in splenic T cell contents, but affected neither the splenic CD4+/CD8+ T cell ratio nor the development of a CTL response upon allogeneic tumor challenge. SSIN mice also had very low splenic natural killer cell activities. Furthermore, relative to the other strains of mice, SSIN mice were poor responders upon alloantigen challenge in mixed lymphocyte response assays. These findings demonstrate that SSIN mice differ markedly from other murine stocks and strains in their splenic lymphocyte composition and in their abilities to mount some MHC-restricted and non-restricted immunosurveillance processes.
在两阶段皮肤致癌方案中,SSIN小鼠对12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)的影响比大多数其他品系和种群的小鼠敏感得多。进行实验以确定这种敏感性是否存在免疫学基础。对SSIN小鼠进行单倍型分析,发现它们是H - 2q。在未处理的SSIN小鼠中,T细胞约占脾细胞总数的31%,而在BALB/c、C57BL/6、B6C3F1和SENCAR小鼠中约占44%。在SSIN、SENCAR、BALB/c、B6C3F1和C57BL/6小鼠中,脾细胞CD4⁺/CD8⁺ T细胞比率分别约为4.2、2.9、2.4、1.8和1.7。SSIN脾中异常高的比率是CD8⁺ T细胞减少的结果。SSIN胸腺细胞中CD4⁺/CD8⁺ T细胞比率与脾中测得的相似。各种鼠品系的脾细胞毒性T淋巴细胞(CTL)活性与它们的脾CD4⁺/CD8⁺比率及其在两阶段皮肤致癌方案中的敏感性呈负相关。用TPA对SSIN小鼠进行反复体内局部处理导致脾T细胞含量显著降低,但既不影响脾CD4⁺/CD8⁺ T细胞比率,也不影响同种异体肿瘤攻击后CTL反应的发展。SSIN小鼠的脾自然杀伤细胞活性也非常低。此外,相对于其他品系的小鼠,SSIN小鼠在混合淋巴细胞反应试验中对同种异体抗原攻击反应较差。这些发现表明,SSIN小鼠在脾淋巴细胞组成以及进行一些MHC限制和非限制免疫监视过程的能力方面与其他鼠种群和品系明显不同。